期刊文献+

DMBA诱导的肝脏特异性IGF-1基因缺失鼠原发性乳腺癌的组织学特征 被引量:3

Histological Features of Primary Mammary Tumor in LID Mice In- duced by 7, 12-Dimethybenz (a) Anthracene
原文传递
导出
摘要 目的 探讨血清中胰岛素样生长因子-1(IGF-1)水平与乳腺肿瘤发生过程中组织学改变的关系。方法 实验中所用的肝脏特异性IGF-1基因缺失(LID)小鼠,其循环中IGF-1水平仅为正常小鼠(对照组小鼠)的25%。管饲化学致癌剂7,12-二甲基苯蒽(DMBA)诱导产生原发性乳腺癌。结果 对照组肿瘤晚期可见广泛的鳞状上皮化生,而LID鼠肿瘤晚期出现广泛增生,极少出现化生。与对照组相比,鼠乳腺肿瘤的潜伏期均明显延长,LID小鼠可触及的乳腺肿瘤发病率明显下降,其肿瘤的出现也明显延迟。结论 在致癌剂DMBA诱导的乳腺肿瘤模型中,IGF-1水平决定了乳腺肿瘤发生的组织学类型。 Objective To investigate the potential relationship between serum IGF-1 level and histological features of mammary cancer. Methods The liver-specific deficient ( LID) mice, in which IGF-1 levels in the circulation were 25% of control levels, were used. Induction of mammary-tumors was achieved by using the 7, 12-dimethybenz (a) anthracene (DMBA). Results Histo-logically, squamous tumors from LID mice demonstrated extensive hyperplasia but little metaplasia. The latency period of mammary tumor development in LID mice was substantially longer. The incidence of palpable mammary tumors was significantly lower in LID mice (26% in LID mice versus 56% in controls) and the onset of the tumors was delayed (74. 0 +1. 2 days in LID mice versus 59. 5 ± 1. 1 days in controls). Conclusion In the established mammary tumor model, circulating IGF-1 levels is the key in the determination of the histological types of primary mammary tumors.
出处 《医学分子生物学杂志》 CAS CSCD 2004年第1期30-32,共3页 Journal of Medical Molecular Biology
  • 相关文献

参考文献12

  • 1Miyoshi K,Shillingford J M,Le Provost F,et al.Activation of beta -catenin signaling in differentiated mammary secretory cells induces transdifferentiation into epidermis and squamous metaplasias.Proc Natl Acad Sci USA,2002,99:219-24.
  • 2Satyamoorthy K,Li G,Vaidya B,et al.Insulin-like growth factor-Ⅰ induces survival and growth of biologically early melanoma cells through both the mitogen-activated protein kinase and beta-catenin pathways.Cancer Res,2001,61:7 318-24.
  • 3Desbois-Mouthon C,Cadoret A,Blivet-Van Eggelpoel MJ,et al.Insulin and IGF-Ⅰ stimulate the beta-catenin pathway through two signalling cascades involving GSK-3beta inhibition and Ras activation.Oncogene,2001,20:252-9.
  • 4Yakar S,Liu JL,Fernandez AM,et al .Liver-specific igf-1 gene deletion leads to muscle insulin insensitivity.Diabetes,2001,50:1 110-8.
  • 5LeRoith D,Baserga R,Helman L,et al.Insulin-like growth factors and cancer.Ann Intern Med,1995,122:54-9.
  • 6Wu Y,Yakar S,Zhao L,et al.Circulating Insulin-like growth factor-I regulate colon cancer growth and metastasis.Cancer Res,2002,62:1 030-5.
  • 7Ruggeri BA,Klurfeld DM,Kritchevsky D,et al.Growth factor binding to 7,12-dimethyl-benz(a)anthracene-induced mammary tumors from rats subject to chronic caloricrestriction.Cancer Res,1989,49:4 135-41.
  • 8Craig-Schmidt M,White M T,Teer P,et al.Menhaden,coconut,and corn oils andmammary tumor incidence in BALB/c virgin female mice treated with DMBA.Nutr Cancer,1993,20:99-106.
  • 9Baserga R.The insulin-like growth factor Ⅰ receptor:a key to tumor growth? Cancer Res,1995,55:249-52.
  • 10Ma J,Pollak MN,Giovannucci E,et al.Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-Ⅰ and IGF-binding protein-3.J Natl Cancer Inst,1999,91:620-5.

同被引文献71

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部